Sponsor study identifier
observational
308
1 country
1
Study Start
April 2006
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
November 2008
Actual (reported)Study Completion
November 2008
Actual (reported)The aims of this study were to identify risk factors associated with delirium in hospitalized persons with dementia, and to describe immediate and post-hospital (1\&3 months) trajectory of cognitive decline and associated outcomes in persons with dementia who develop delirium. It was hypothesized that factors such as CNS-active medications, urinary tract infection, stage of dementia, pain, activity level, and dehydration would be associated with an increased risk of delirium and delirium severity in patients with dementia compared to dementia patients without delirium. It was also hypothesized that persons with DSD will have worse outcomes (longer hospital length of stays, decreased functional status, a steeper negative slope of cognitive decline) than dementia patients without delirium. Lastly, it was hypothesized that higher delirium severity would be associated with poorer outcomes in persons with dementia. The long-term objectives were to use the results from this study to design and test an intervention strategy to improve early recognition, management, prevention, and outcomes in persons with DSD.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 2008
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 2006
Date type not reportedThis date has not been verified as actual or estimated.
November 2008
Actual (reported)November 2008
Actual (reported)July 11, 2011
Actual (reported)July 14, 2011
Actual (reported)Change in Delirium status during hospital stay
Confusion Assessment Method (CAM)and Delirium Rating Scale (DRS) were used to measure delirium.
Participants will be assessed daily until discharge (duration of hospitalization), which is expected to be about 5 days
Change in Delirium status at 1 month after discharge
Confusion Assessment Method (CAM)and Delirium Rating Scale (DRS) were used to measure delirium.
Participants will be assessed 1 month after date of hospital discharge
Change in Delirium status at 3 months after discharge
Confusion Assessment Method (CAM)and Delirium Rating Scale (DRS) were used to measure delirium.
Participants will be assessed 3 months after date of hospital discharge
Hospitalization Length of Stay
Duration of hospitalization, expected to be about 5 days
Change in Functional Status during hospital stay
Daily until discharge, expected to be about 5 days
Change in Functional Status at 1 month after discharge
Participant will be assessed 1 month after date of hospital discharge
Change in Functional Status at 3 months after discharge
Participant will be assessed 3 months after date of hospital discharge
Change in Cognitive Decline during hospital stay
Daily until discharge, expected to be about 5 days
Persons with Dementia are identified by the Modified Blessed Dementia Rating Scale and the IQCODE
165 hospitalized older adults at Mount Nittany Medical Center, age 65 and older with Dementia.
Mount Nittany Medical Center
State College, Pennsylvania, 16801, United States
Donna Fick, PhD
Penn State University
308 participants (actual enrollment reported by the registry).
First Submitted
July 11, 2011
First Posted
July 14, 2011
Study Start
April 2006
Date type not reportedThis date has not been verified as actual or estimated.
Prevalence of Dementia and Delirium in Outpatient Clinics (DESTAN Trial)
Contact the study team to confirm eligibility.
Primary Completion
November 2008
Actual (reported)Study Completion
November 2008
Actual (reported)Last Updated
January 16, 2018
Record last verified: 2018-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: